Debate over stem cell bill intensifies

07/17/2006 | Washington Post (tiered subscription model), The

A House-passed stem cell research bill, allowing the use of federal funds for new lines of stem cells, is drawing fiery exchanges between opponents and proponents. The debate focuses on whether easily-harvested adult stem cells could prove as promising as embryonic cells that only can come from destroyed embryos. Three scientific proponents wrote a letter to the journal Science and, point-by-point, explained that the conclusions reached by a conservative scientist who had said adult stem cells had as much potential as embryonic ones were wrong.

View Full Article in:

Washington Post (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park